I posted this a while back, but I think its worth revsiting..
Not saying that Roche and BMSN are merging, not in the least..
but with all the rumors flying around, the drugs theyre both coming up with seem very similar..
Comparing Roche and BMSN
ROCHE-RHHBY Obinutuzumab
ZURICH -- Roche Holding AG (ROG.VX) Thursday said the first stage of a phase III study showed Obinutuzumab (GA101) significantly improved progression-free survival in people with chronic lymphocytic leukemia.
BMSN-HemaXellerate
HemaXellerate™ is a cell therapy product developed by Regen BioPharma that uses fat derived from the patient as a source of "healing cells" to stimulate bone marrow production of blood cells. These "healing cells" are termed "endothelial cells" and are a critical component of the blood production machinery of the bone marrow that is damaged in patients with bone marrow failure.
Im no medical expert, but there research sounds very parallel.
dont know if it has any significance or not, just thought it was worth pointing out.
